|
|
Volumn 13, Issue 3, 2015, Pages 156-165
|
|
Public funding of clinical-stage antibiotic development in the United States and European Union
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIINFECTIVE AGENT;
DRUG DEVELOPMENT;
ECONOMICS;
EUROPEAN UNION;
FINANCIAL MANAGEMENT;
GOVERNMENT;
HEALTH CARE POLICY;
HUMAN;
MEDICAL RESEARCH;
ORGANIZATION AND MANAGEMENT;
PATENT;
PROCEDURES;
TECHNOLOGY;
UNITED STATES;
ANTI-BACTERIAL AGENTS;
BIOMEDICAL RESEARCH;
DRUG DISCOVERY;
EUROPEAN UNION;
FINANCING, GOVERNMENT;
GOVERNMENT PROGRAMS;
HEALTH POLICY;
HUMANS;
INTELLECTUAL PROPERTY;
TECHNOLOGY TRANSFER;
UNITED STATES;
UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;
|
|
EID: 85018236686
PISSN: None
EISSN: 23265108
Source Type: Journal
DOI: 10.1089/hs.2014.0081 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|